-
Scientists watch a Parkinson's protein pierce neuron membranes for the first time
12 Dec 2025 15:29 GMT
Scientists have directly watched a Parkinson’s protein punch tiny, shifting holes in lab-grown brain cell membranes for the first time.
The work helps explain how Parkinson’s disease, which affects more than 10 million people worldwide, slowly wears …
-
Parkinson's Disease in Transition: Genetics, Biomarkers, and Emerging Therapeutics
12 Dec 2025 14:31 GMT
Authors:
Sung-Pin Fan, Ayami Okuzumi, Pin-Shiuan Chen, Yi-Cheng Tai, Yih-Chih Kuo, Chun-Hwei Tai, Cheng-Hsuan Li, Han-Lin Chiang, Taku Hatano, Chin-Hsien Lin
Abstract
Parkinson's disease (PD) is the fastest-growing neurological disorder worldwide, …
-
Fighting back: Sara Huntley helps Parkinson's patients stay strong through boxing
12 Dec 2025 06:06 GMT
After more than three decades spent troubleshooting computer problems at the University of North Alabama, Sara Huntley traded in her keyboard for boxing gloves.
×
Javascript is required for you to be able to read premium content. Please enable it in your …
-
Sixty-seven year old with Parkinson's disease proves its never too late for skydiving
11 Dec 2025 23:41 GMT
Olivia Young
Carol Weingrod has lived with Parkinson’s disease for the last seven years, a brain condition that disrupts balance and movement. But on Friday, as the wind tunnel wafted her up and down, arms outstretched and cheeks fluttering from the rush …
-
Shrinking Boss Bill Lawrence Teases Paul's Parkinson's Struggles, Jimmy's Romantic Future In Season 3 (Exclusive First Look)
11 Dec 2025 22:01 GMT
It's time for Jimmy to move on.
Apple TV's "Shrinking" returns for Season 3 Wednesday, Jan. 28 with a one-hour premiere, and while it's high-time for Jimmy's life to move forward, he won't be the only character either making …
-
AC Immune says Parkinson's drug slows progression
11 Dec 2025 20:34 GMT
Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing down the progression of Parkinson's disease.
The results of the phase 2 VacSYn trial of ACI-7104.056 in patients with early-stage …
-
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's
11 Dec 2025 18:07 GMT
AC Immune SA (NASDAQ:ACIU) on Thursday released interim safety and efficacy results from the Phase 2 VacSYn trial of its anti-alpha-synuclein (a-syn) active immunotherapy ACI-7104.056 in early Parkinson’s disease.
The results show, for the first time, that …
-
AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear
11 Dec 2025 17:00 GMT
Swiss biotech AC Immune, researching immunological treatments for neurodegenerative disorders, reported interim Parkinson’s disease data Thursday, suggesting it may slow the progression of the condition …
-
Restless leg syndrome may increase Parkinson's disease risk, study…
11 Dec 2025 08:23 GMT
Restless leg syndrome is a sleep and movement disorder that impacts many people in the United States alone.
A recent population-based cohort study in the Republic of Korea found that having restless leg syndrome is associated with a higher likelihood of …
-
Van Andel Institute, Cure Parkinson's Renew Funding for Parkinson's Clinical Trials Program
11 Dec 2025 03:28 GMT
Newswise — GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug repurposing clinical trial initiative for …